Login to Your Account

Good Times Ahead for Cell Therapy?

Pathfinder Going Public Via SyntheMed Reverse Merger

By Tom Wall

Monday, December 27, 2010
Believing that it's a good time to access capital and make a move in the cell therapy space, Pathfinder LLC, of Cambridge, Mass., will become a public company via a reverse merger with biomaterials company SyntheMed Inc., of Iselin, N.J.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription